NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of AST SpaceMobile, Inc. ("AST" or the "Company") (NASDAQ:ASTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether AST and certain of its officers and/or […]
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Duluth Holdings Inc. ("Duluth" or the "Company") (NASDAQ:DLTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Duluth and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Air Products and Chemicals, Inc. ("Air Products" or the "Company") (NYSE:APD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Air Products and certain
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Cogent Communications Holdings, Inc. ("Cogent" or the "Company") (NASDAQ:CCOI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Cogent and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ:INO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Inovio and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation ("Xoma" or the "Company") (NASDAQ:XOMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Xoma and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Instil Bio, Inc. ("Instil" or the "Company") (NASDAQ:TIL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Instil and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (NASDAQ:VNDA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Vanda and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Trip.com Group Limited ("Trip.com" or the "Company") (NASDAQ:TCOM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Trip.com and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / January 25, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Wealthfront Corporation ("Wealthfront" or the "Company") (NASDAQ:WLTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Wealthfront and certain of its officers and/or directors